全球组织诊断市场

预计到 2030 年全球组织诊断市场规模将达 95 亿美元

全球组织诊断市场规模预计在2024年为65亿美元，预计到2030年将达到95亿美元，2024年至2030年的复合年增长率为6.6%。报告分析的细分市场之一——耗材——预计复合年增长率为6.8%，到分析期结束时规模将达到84亿美元。设备细分市场在分析期间内的复合年增长率预计为5.2%。

美国市场规模估计为 22 亿美元，中国市场预期复合年增长率为 9.2%

美国诊断市场规模预计2024年达到22亿美元。作为世界第二大经济体，中国预计到2030年市场规模将达到10亿美元，在2024-2030年的分析期间内，复合年增长率为9.2%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为4.9%和6.2%。在欧洲，预计德国市场的复合年增长率为5.6%。

全球组织诊断市场—主要趋势与驱动因素摘要

什么是组织诊断？为什么它很重要？

组织病理学涉及透过分析组织样本来诊断疾病，尤其是癌症。此领域涵盖组织病理学、免疫组织化学、原位杂合反应和数位病理学等技术。组织病理学对于准确的疾病诊断、预后和治疗计划至关重要。它可以检查细胞结构、识别异常细胞，并检测与各种疾病相关的特定生物标记。组织病理学的准确性和可靠性对于指南临床决策和改善患者预后至关重要。

科技进步如何影响这个市场？

技术进步正在显着塑造组织诊断市场。数位病理学的发展，将组织样本数位化以供分析和存储，正在彻底改变这一领域。数位病理学实现了远距会诊，提高了诊断准确性，并促进了研究和教育的数据共用。高解析度扫描器和人工智慧驱动的影像分析等成像技术的进步，正在改善组织异常的检测和表征。此外，分子诊断与组织分析的结合，为深入了解疾病的遗传和分子基础提供了更深入的视角，从而带来更个人化和标靶治疗。

市场需求在这个产业扮演什么角色？

市场需求正在推动组织诊断市场发生重大变化。癌症和其他慢性疾病的发生率不断上升，推动了对准确及时诊断的需求，从而增加了对先进组织诊断工具的需求。个人化医疗的转变需要详细的分子和基因分析，这正在影响创新组织诊断技术的开发和应用。老年人口的增长，导致各种疾病的发生率更高，进一步增加了对先进诊断设备的需求。此外，对疾病早期发现和预防性医疗保健的日益重视，也促使实验室和医疗机构投资于尖端组织诊断解决方案。

推动市场成长的因素有哪些？

组织诊断市场的成长受到多种因素的推动，例如癌症和其他慢性病盛行率的上升、诊断技术的进步以及医疗支出的增加。由于早期发现可显着改善治疗效果，对精准早期诊断工具的需求正在推动市场成长。数位病理学和人工智慧主导的诊断工具等技术创新正在提高疾病诊断的效率和准确性。此外，个人化医疗的日益增长趋势推动了对能够提供详细分子和遗传学见解的先进组织诊断技术的需求。新兴市场医疗基础设施的扩大以及政府为提高诊断能力所采取的措施也促进了市场的成长。这些因素共同导致了对组织诊断的强劲需求，从而推动了市场的发展。

部分

产品（耗材、仪器）、技术（免疫组织化学、原位杂合反应、特殊染色、数位病理学和工作流程）、最终用户（医院、製药公司、研究实验室、其他最终用户）

受访公司范例（总合61家）

• Abbott Laboratories
• Abcam plc
• Agilent Technologies, Inc.
• Becton, Dickinson and Company
• Bio SB Inc.
• Bio-Genex Laboratories
• Cell Signaling Technology, Inc.
• F. Hoffmann-La Roche Ltd
• Leica Biosystems Nussloch GmbH
• Merck KGaA
• QIAGEN NV
• Sakura Finetek Japan Co., Ltd.
• Thermo Fisher Scientific Inc.

人工智慧集成

全球产业分析师正在利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global Industry Analysts 并未遵循典型的 LLM 或特定产业的 SLM查询，而是建立了一个从全球专家收集的内容库，其中包括影片录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地、进出口状况（成品和原始OEM）预测其竞争态势的变化。这种复杂且多面向的市场动态预计将以多种方式影响竞争对手，包括销货成本成本 (COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

• 市场概览
• 主要企业
• 市场趋势和驱动因素
• 全球市场展望

第三章市场分析

• 美国
• 加拿大
• 日本
• 中国
• 欧洲
• 法国
• 德国
• 义大利
• 英国
• 西班牙
• 俄罗斯
• 其他欧洲国家
• 亚太地区
• 澳洲
• 印度
• 韩国
• 其他亚太地区
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中东
• 伊朗
• 以色列
• 沙乌地阿拉伯
• 阿拉伯聯合大公国
• 其他中东地区
• 非洲

第四章 竞赛

Global Tissue Diagnostics Market to Reach US$9.5 Billion by 2030

The global market for Tissue Diagnostics estimated at US$6.5 Billion in the year 2024, is expected to reach US$9.5 Billion by 2030, growing at a CAGR of 6.6% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$8.4 Billion by the end of the analysis period. Growth in the Instruments segment is estimated at 5.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.2 Billion While China is Forecast to Grow at 9.2% CAGR

The Tissue Diagnostics market in the U.S. is estimated at US$2.2 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.0 Billion by the year 2030 trailing a CAGR of 9.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.9% and 6.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.6% CAGR.

Global Tissue Diagnostics Market - Key Trends & Drivers Summarized

What Are Tissue Diagnostics and Their Importance?

Tissue diagnostics involves the analysis of tissue samples to diagnose diseases, particularly cancer. This field includes techniques such as histopathology, immunohistochemistry, in situ hybridization, and digital pathology. Tissue diagnostics is crucial for accurate disease diagnosis, prognosis, and treatment planning. It allows for the examination of cellular structures, the identification of abnormal cells, and the detection of specific biomarkers associated with various diseases. The precision and reliability of tissue diagnostics are vital for guiding clinical decisions and improving patient outcomes.

How Are Technological Advancements Shaping This Market?

Technological advancements are significantly shaping the tissue diagnostics market. The development of digital pathology, which involves the digitization of tissue samples for analysis and storage, is revolutionizing the field. Digital pathology enables remote consultations, enhances diagnostic accuracy, and facilitates the sharing of data for research and education. Advances in imaging technologies, such as high-resolution scanners and AI-powered image analysis, are improving the detection and characterization of tissue abnormalities. Additionally, the integration of molecular diagnostics with tissue analysis is providing deeper insights into the genetic and molecular underpinnings of diseases, leading to more personalized and targeted therapies.

What Role Do Market Demands Play in This Industry?

Market demands are driving significant changes in the tissue diagnostics market. The rising prevalence of cancer and other chronic diseases is increasing the need for accurate and timely diagnostics, boosting demand for advanced tissue diagnostic tools. The shift towards personalized medicine, which requires detailed molecular and genetic analysis, is influencing the development and adoption of innovative tissue diagnostics technologies. The expanding geriatric population, with its higher incidence of various diseases, further fuels the need for sophisticated diagnostic instruments. Moreover, the increasing focus on early disease detection and preventive healthcare is prompting laboratories and healthcare facilities to invest in cutting-edge tissue diagnostics solutions.

What Factors Are Driving Market Growth?

The growth in the tissue diagnostics market is driven by several factors, including the rising incidence of cancer and other chronic diseases, advancements in diagnostic technologies, and increasing healthcare expenditure. The demand for precise and early diagnostic tools is propelling market growth, as early detection can significantly improve treatment outcomes. Technological innovations, such as digital pathology and AI-driven diagnostic tools, are enhancing the efficiency and accuracy of disease diagnosis. Additionally, the growing trend towards personalized medicine is driving the need for advanced tissue diagnostics that can provide detailed molecular and genetic insights. The expansion of healthcare infrastructure in emerging markets, along with government initiatives to improve diagnostic capabilities, is also contributing to the market's growth. These factors collectively ensure a robust demand for tissue diagnostics, driving the market forward.

SCOPE OF STUDY:

The report analyzes the Tissue Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Consumables, Instruments); Technology (Immunohistochemistry, In Situ Hybridization, Special Staining, Digital Pathology & Workflow); End-Use (Hospitals, Pharma Companies, Research Laboratories, Other End-Uses)

Geographic Regions/Countries:

World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.

Select Competitors (Total 61 Featured) -

• Abbott Laboratories
• Abcam plc
• Agilent Technologies, Inc.
• Becton, Dickinson and Company
• Bio SB Inc.
• Bio-Genex Laboratories
• Cell Signaling Technology, Inc.
• F. Hoffmann-La Roche Ltd
• Leica Biosystems Nussloch GmbH
• Merck KGaA
• QIAGEN N.V.
• Sakura Finetek Japan Co., Ltd.
• Thermo Fisher Scientific Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Tariff Impact on Global Supply Chain Patterns
  • Tissue Diagnostics: A Prelude
  • Global Economic Update
  • Global Market Outlook
  • Immunohistochemistry Emerges as the Major Tissue Diagnostic Test
  • Breast Cancer Leads the Application Market for Tissue Diagnostics
  • Hospitals Represent the Leading End-Use Segment
  • Developed Regions Lead, Developing Economies to Spearhead Growth
  • Competition
  • Tissue Diagnostics - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • Recent Market Activity
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Cancer Incidence Worldwide Spurs Demand for Tissue Diagnostics
  • Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
  • Expanding Role of Tissue Diagnostics in Oncology
  • Aging Population and Changing Lifestyles Drive Cancer Incidence, Fueling Prospects for Tissue Diagnostics Market
  • Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
  • Increasing Healthcare Spending Augurs Well for the Market
  • Growing Significance of Personalized Medicine: An Opportunity for Tissue Diagnostics Market
  • Global Personalized Medicines Market in US$ Billion for the Years 2022, 2024, 2026 and 2028
  • Liquid Biopsies Grow in Value as a Diagnostic Tool Supporting Therapy Decisions in NSCLCs
  • Sustained Advancements in Tissue Diagnostics Space Fuel Market Prospects
  • Market to Benefit from Digitalization of Tissue Diagnostic Techniques & Automated Tissue Diagnostic Systems
  • Increase in Companion Diagnostics for Targeted Therapies
  • Companion Diagnostics Accelerate Role of Personalized Medicine in Cancer Care
  • Demand Continues to Surge for Digital Pathology
  • Digital Pathology Emerges as a Tool to Reduce Cases of Cancer Misdiagnoses
  • Future Developments in Digital Pathology to Influence Market Growth
  • AI Steps in to Widen the Scope & Span of Digital Pathology
  • Growing Importance of AI in Digital Pathology
  • CROs and Biopharma Companies Leverage Digital Pathology for Drug Discovery
  • Anatomic Pathology: Poised for Growth
  • Computational Pathology Holds the Potential to Transform Cancer Diagnostics
  • Constantly Increasing Number of Patients Suffering from Chronic Ailments Fuel Demand for Immunohistochemistry
  • Automated Tissue Dissection: Potential to Improve Precision of Molecular Tests
  • Tissue Diagnostics Market in India: An Overview
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Tissue Diagnostics Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Tissue Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Tissue Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Tissue Diagnostics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Immunohistochemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Immunohistochemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Immunohistochemistry by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for in Situ Hybridization by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for in Situ Hybridization by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for in Situ Hybridization by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Special Staining by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Special Staining by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Special Staining by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Digital Pathology & Workflow by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Digital Pathology & Workflow by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Digital Pathology & Workflow by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Pharma Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Pharma Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Pharma Companies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Research Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Research Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Research Laboratories by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Tissue Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 35: USA Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 36: USA Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 37: USA 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
  • TABLE 38: USA Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 40: USA 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
  • TABLE 41: USA Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 43: USA 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 44: Canada Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Canada Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 46: Canada 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
  • TABLE 47: Canada Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Canada Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 49: Canada 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 52: Canada 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
• JAPAN
  • Tissue Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 53: Japan Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Japan Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 55: Japan 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
  • TABLE 56: Japan Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Japan Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 58: Japan 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
  • TABLE 59: Japan Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 61: Japan 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
• CHINA
  • Tissue Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 62: China Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 63: China Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 64: China 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
  • TABLE 65: China Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 66: China Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 67: China 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
  • TABLE 68: China Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: China Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 70: China 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
• EUROPE
  • Tissue Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 71: Europe Recent Past, Current & Future Analysis for Tissue Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for Tissue Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 73: Europe 15-Year Perspective for Tissue Diagnostics by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 76: Europe 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 79: Europe 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
  • TABLE 80: Europe Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 82: Europe 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
• FRANCE
  • Tissue Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 83: France Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 84: France Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 85: France 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
  • TABLE 86: France Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: France Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 88: France 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
  • TABLE 89: France Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 90: France Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 91: France 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
• GERMANY
  • Tissue Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 92: Germany Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Germany Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 94: Germany 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
  • TABLE 95: Germany Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Germany Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 97: Germany 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
  • TABLE 98: Germany Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Germany Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 100: Germany 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 101: Italy Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Italy Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 103: Italy 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
  • TABLE 104: Italy Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Italy Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 106: Italy 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
  • TABLE 107: Italy Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Italy Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 109: Italy 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Tissue Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 110: UK Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 111: UK Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 112: UK 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
  • TABLE 113: UK Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 114: UK Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 115: UK 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
  • TABLE 116: UK Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 117: UK Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 118: UK 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 119: Spain Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Spain Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 121: Spain 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
  • TABLE 122: Spain Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Spain Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 124: Spain 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
  • TABLE 125: Spain Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Spain Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 127: Spain 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 128: Russia Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Russia Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 130: Russia 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
  • TABLE 131: Russia Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Russia Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 133: Russia 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
  • TABLE 134: Russia Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Russia Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 136: Russia 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Rest of Europe Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 139: Rest of Europe 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
  • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Rest of Europe Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 142: Rest of Europe 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
  • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Rest of Europe Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 145: Rest of Europe 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Tissue Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Tissue Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 147: Asia-Pacific Historic Review for Tissue Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 148: Asia-Pacific 15-Year Perspective for Tissue Diagnostics by Geographic Region - Percentage Breakdown of Value Revenues for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 151: Asia-Pacific 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Tissue Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 158: Australia Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Australia Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 160: Australia 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
  • TABLE 161: Australia Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Australia Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 163: Australia 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
  • TABLE 164: Australia Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Australia Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 166: Australia 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
• INDIA
  • Tissue Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 167: India Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 168: India Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 169: India 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
  • TABLE 170: India Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 171: India Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 172: India 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
  • TABLE 173: India Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 174: India Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 175: India 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 176: South Korea Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 177: South Korea Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 178: South Korea 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
  • TABLE 179: South Korea Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 180: South Korea Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 181: South Korea 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
  • TABLE 182: South Korea Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 183: South Korea Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 184: South Korea 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Asia-Pacific Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
  • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Asia-Pacific Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
  • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Asia-Pacific Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Tissue Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 194: Latin America Recent Past, Current & Future Analysis for Tissue Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 195: Latin America Historic Review for Tissue Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 196: Latin America 15-Year Perspective for Tissue Diagnostics by Geographic Region - Percentage Breakdown of Value Revenues for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 199: Latin America 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 202: Latin America 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 205: Latin America 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 206: Argentina Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Argentina Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 208: Argentina 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
  • TABLE 209: Argentina Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Argentina Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 211: Argentina 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
  • TABLE 212: Argentina Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Argentina Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 214: Argentina 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 215: Brazil Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Brazil Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 217: Brazil 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
  • TABLE 218: Brazil Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Brazil Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 220: Brazil 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
  • TABLE 221: Brazil Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Brazil Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 223: Brazil 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 224: Mexico Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Mexico Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 226: Mexico 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
  • TABLE 227: Mexico Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Mexico Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 229: Mexico 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
  • TABLE 230: Mexico Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Mexico Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 232: Mexico 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Rest of Latin America Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 235: Rest of Latin America 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
  • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Latin America Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 238: Rest of Latin America 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
  • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Latin America Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 241: Rest of Latin America 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Tissue Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 242: Middle East Recent Past, Current & Future Analysis for Tissue Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 243: Middle East Historic Review for Tissue Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 244: Middle East 15-Year Perspective for Tissue Diagnostics by Geographic Region - Percentage Breakdown of Value Revenues for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 247: Middle East 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 250: Middle East 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 253: Middle East 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 254: Iran Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Iran Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 256: Iran 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
  • TABLE 257: Iran Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Iran Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 259: Iran 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
  • TABLE 260: Iran Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Iran Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 262: Iran 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 263: Israel Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Israel Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 265: Israel 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
  • TABLE 266: Israel Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Israel Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 268: Israel 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
  • TABLE 269: Israel Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Israel Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 271: Israel 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Saudi Arabia Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 274: Saudi Arabia 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
  • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Saudi Arabia Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 277: Saudi Arabia 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
  • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Saudi Arabia Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 280: Saudi Arabia 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 281: UAE Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 282: UAE Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 283: UAE 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
  • TABLE 284: UAE Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 285: UAE Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 286: UAE 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
  • TABLE 287: UAE Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 288: UAE Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 289: UAE 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Rest of Middle East Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 292: Rest of Middle East 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
  • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Rest of Middle East Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 295: Rest of Middle East 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
  • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Rest of Middle East Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 298: Rest of Middle East 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
• AFRICA
  • Tissue Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 299: Africa Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Africa Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 301: Africa 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
  • TABLE 302: Africa Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Africa Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 304: Africa 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
  • TABLE 305: Africa Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Africa Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 307: Africa 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION